전임상 이미징 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global preclinical imaging market size is expected to reach USD 7.54 Billion in 2034 from USD 4.90 Billion in 2025, growing at a CAGR of 4.91 during 2026-2034.This market is expanding rapidly as pharmaceutical and biotechnology companies increasingly rely on advanced imaging technologies to accelerate drug discovery and development. Preclinical imaging systems, including MRI, CT, PET, and optical imaging, are used to study disease progression and evaluate therapeutic responses in animal models. The growing emphasis on precision medicine and the need for early-stage validation of drug efficacy are significantly driving market growth. Additionally, rising investments in research and development activities across the life sciences sector are further contributing to the expansion of this market.

Key growth drivers include technological advancements and the increasing demand for non-invasive imaging techniques. Modern preclinical imaging systems offer high-resolution and real-time insights, enabling researchers to monitor biological processes more effectively. The expansion of academic research institutions and contract research organizations is also supporting market growth. Furthermore, the increasing prevalence of chronic diseases is encouraging the development of new therapies, which in turn drives demand for advanced imaging solutions.

Future prospects for this market remain highly promising, with continued innovation expected to enhance imaging capabilities and efficiency. The integration of artificial intelligence and data analytics will improve image interpretation and accelerate research outcomes. Emerging markets are likely to witness significant growth due to expanding research infrastructure. As the demand for advanced drug development tools continues to rise, the preclinical imaging market is poised for sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• CT Imaging
• MRI Imaging
• PET/SPECT Imaging
• Multi-modal Imaging
• Optical Imaging
• Ultrasound Imaging
• Photoacoustic Imaging
• Reagents
• Services

By Application

• Research and Development
• Drug Discovery

By End-use

• Pharma and Biotech Companies
• Research Institutes
• Others

COMPANIES PROFILED

• Bruker Corporation, Siemens A.G., General Electric (GE), TriFoil Imaging, PerkinElmer Inc., Fujifilm SonoSite, Mediso Ltd., Agilent Technologies, MILabs B.V., MR Solutions, Molecubes.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PRECLINICAL IMAGING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. CT Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. MRI Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. PET/SPECT Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Multi-modal Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Optical Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Ultrasound Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Photoacoustic Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRECLINICAL IMAGING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Research and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRECLINICAL IMAGING MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Pharma and Biotech Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PRECLINICAL IMAGING MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PRECLINICAL IMAGING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Bruker Corporation
  • 9.2.2 Siemens A.G
  • 9.2.3 General Electric (GE)
  • 9.2.4 TriFoil Imaging
  • 9.2.5 PerkinElmer Inc
  • 9.2.6 Fujifilm SonoSite
  • 9.2.7 Mediso Ltd
  • 9.2.8 Agilent Technologies
  • 9.2.9 MILabs B.V
  • 9.2.10 MR Solutions
  • 9.2.11 Molecubes